Stay updated on IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Sign up to get notified when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.
Latest website image capture
Clouds background image

Latest updates to the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page

  1. Check
    today
    Change Detected
    Summary
    The site footer revision changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-16T15:23:22.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-09T15:40:44.000Z thumbnail image
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden message, replacing the previous study record content with a basic header. This change eliminates access to the detailed study information and related sections that were previously visible on the page.
    Difference
    19%
    Check dated 2026-09-25T20:42:13.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.6 to v3.7.0, indicating an update to the site’s template or documentation; this is a minor version increment that does not modify the study content.
    Difference
    0.0%
    Check dated 2026-09-18T17:27:55.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Added an NIH grant/contract identifier for 2017 to the study's identifiers. Updated the page revision to v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-28T19:21:13.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    A new publication citation regarding hyperprogressive disease in the IMbrave150 trial was added to the study publications, and the page revision was updated from v3.6.4 to v3.6.5.
    Difference
    0.0%
    Check dated 2026-08-07T12:35:14.000Z thumbnail image

Stay in the know with updates to IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib

Enter your email address, and we'll notify you when there's something new on the IMbrave150 Clinical Trial: Atezo-Bev vs. Sorafenib page.